Intravenous Amoxicillin Plus Intravenous Gentamicin for Children with Severe Pneumonia in Bangladesh: An Open-Label, Randomized, Non-Inferiority Controlled Trial

Intravenous Amoxicillin Plus Intravenous Gentamicin for Children with Severe Pneumonia in Bangladesh: An Open-Label, Randomized, Non-Inferiority Controlled Trial

The World Health Organization (WHO) recommends intravenous (IV) ampicillin and gentamicin as first-line therapy to treat severe pneumonia in children under five years of age. Ampicillin needs to be administered at a six-hourly interval, which requires frequent nursing intervention and bed occupancy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubaba Shahrin, Mohammod Jobayer Chisti, Monira Sarmin, Abu Sayem Mirza Md. Hasibur Rahman, Abu Sadat Mohammad Sayeem Bin Shahid, Md. Zahidul Islam, Farzana Afroze, Sayeeda Huq, Tahmeed Ahmed
Formato: Artículo
Lenguaje:English
Publicado: MDPI AG 2021-11-01
Colección:Life
Materias:
amoxicillin
severe pneumonia
randomized controlled trial
children treatment failure
Acceso en línea:https://www.mdpi.com/2075-1729/11/12/1299

Internet

https://www.mdpi.com/2075-1729/11/12/1299

Ejemplares similares